| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/27/2011 | EP2346524A2 New therapy and medicament using integrin ligands for treating cancer |
| 07/27/2011 | EP2346522A1 Methods of modulating protein homeostasis, metabolic syndrome, heavy metal intoxication and nrf2 transcription factors |
| 07/27/2011 | EP2346520A1 Curcuminoids and its metabolites for the application in ocular diseases |
| 07/27/2011 | EP2346513A1 Compositions comprising polymers having amino sugar units and methods of making and using same |
| 07/27/2011 | EP2346512A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 07/27/2011 | EP2346511A2 Method for treating pulmonary arterial hypertension |
| 07/27/2011 | EP2346510A1 Use of triterpenic and anthraquinone glycosides as substances exerting hydragogue activity on mucosa of the upper respiratory tract, for the treatment of upper respiratory tract diseases |
| 07/27/2011 | EP2346509A1 Inhalation of levofloxacin for reducing lung inflammation |
| 07/27/2011 | EP2346508A1 Heterocyclic kinase inhibitors |
| 07/27/2011 | EP2346507A1 Use of quinazoline derivatives for the treatment of viral diseases |
| 07/27/2011 | EP2346506A1 Administration scheme of polar opioid metabolites for post-operative pain management |
| 07/27/2011 | EP2346504A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 07/27/2011 | EP2346503A2 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia |
| 07/27/2011 | EP2346502A1 Derivatives of hypoestoxides for the treatment of malaria |
| 07/27/2011 | EP2346501A1 Use of cationic surfactants for the inactivation of toxins |
| 07/27/2011 | EP2346500A1 Methods and compositions for improving cognitive function |
| 07/27/2011 | EP2346499A1 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 07/27/2011 | EP2346498A1 Methods of reducing small, dense ldl particles |
| 07/27/2011 | EP2346497A1 Compound for local deletion of tumors |
| 07/27/2011 | EP2346492A2 A process for nanoemulsification of curcumin and derivatives of curcumin |
| 07/27/2011 | EP2346491A1 Novel pharmaceutical uses for nanoparticles |
| 07/27/2011 | EP2346486A1 Novel anti-stretch mark active agent, and compositions containing same |
| 07/27/2011 | EP2346427A1 Methods for improved cryo-chemotherapy tissue ablation |
| 07/27/2011 | EP2346357A1 Pet food composition comprising an antioxidant component |
| 07/27/2011 | EP2346352A1 Nutritional composition with anti-regurgitation properties |
| 07/27/2011 | EP2346350A1 Use of azaperone for reducing antibiotic usage |
| 07/27/2011 | EP2346349A1 Use of azaperone for improving growth performance |
| 07/27/2011 | EP2346334A1 Oxazolobenzimidazole derivatives |
| 07/27/2011 | EP2346332A1 Pyrido (4,3-b) indoles containing rigid moieties |
| 07/27/2011 | EP2346330A1 Antimicrobial compositions and uses |
| 07/27/2011 | EP2346329A1 A method of inhibiting hepatitis c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds |
| 07/27/2011 | EP2125726B1 Spiro-piperidine derivatives |
| 07/27/2011 | EP2061762B1 Pyrazine compounds, their use and methods of preparation |
| 07/27/2011 | EP2040702B1 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
| 07/27/2011 | EP2032126B1 Rabeprazole formulation |
| 07/27/2011 | EP2029134B1 Stabilized pharmaceutical compositions comprising fesoterodine |
| 07/27/2011 | EP2016073B1 Process for the preparation of pure irbesartan |
| 07/27/2011 | EP2013213B1 Constrained compounds as cgrp-receptor antagonists |
| 07/27/2011 | EP1992622B1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| 07/27/2011 | EP1951697B1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines |
| 07/27/2011 | EP1948617B1 Pyrimidinones as casein kinase ii (ck2) modulators |
| 07/27/2011 | EP1945626B1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 07/27/2011 | EP1943224B1 Estrogen receptor modulators |
| 07/27/2011 | EP1937678B1 Hiv integrase inhibitors |
| 07/27/2011 | EP1932523B1 Adhesive preparation containing bisoprolol |
| 07/27/2011 | EP1907389B1 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| 07/27/2011 | EP1878738B1 1-kestose for treating allergy and atopic dermatitis |
| 07/27/2011 | EP1869037B1 Heterobicylic inhibitors of hvc |
| 07/27/2011 | EP1866302B1 Pyrazole derivatives |
| 07/27/2011 | EP1856070B1 Novel drugs for treating respiratory diseases |
| 07/27/2011 | EP1855660B1 Non-fibrous transdermal therapeutic system and method for its production |
| 07/27/2011 | EP1855657B1 Dosage form containing oxycodone and naloxone |
| 07/27/2011 | EP1848695B1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 07/27/2011 | EP1845780B1 Uses of methylphenidate derivatives |
| 07/27/2011 | EP1841780B1 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 07/27/2011 | EP1805166B1 Quinoline derivatives |
| 07/27/2011 | EP1797096B1 Pyrazolopyrimidines as inhibitors of protein kinase b (akt) |
| 07/27/2011 | EP1753746B1 Novel pyrrole derivatives with angiotensin ii antagonist activity |
| 07/27/2011 | EP1744746B1 Use of melatonin in preventing postoperative complications |
| 07/27/2011 | EP1741434B1 USE OF TIMOSAPONIN BII for TREATING STROKE |
| 07/27/2011 | EP1740156B1 Method for the production of an abuse-proof, solid form of administration |
| 07/27/2011 | EP1709046B1 P38 kinase inhibitors |
| 07/27/2011 | EP1689713B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 07/27/2011 | EP1682135B1 salt of a tetrahydropyranyl cyclopentyl tetrahydropyridopyridine derivative as CCR2-antagonist |
| 07/27/2011 | EP1641764B1 5-membered heterocycle-based p38 kinase inhibitors |
| 07/27/2011 | EP1638568B1 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 07/27/2011 | EP1601646B1 2-substituted vitamin d analogues and their therapeutic uses |
| 07/27/2011 | EP1598349B1 Novel 2-pyridinecarboxamide derivatives |
| 07/27/2011 | EP1534284B1 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 07/27/2011 | EP1490355B1 Indolylmaleimide derivatives |
| 07/27/2011 | EP1474415B1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases |
| 07/27/2011 | EP1461025B1 Treatment of parkinson's disease with cape |
| 07/27/2011 | EP1443928B1 Treatment of neurodegenerative diseases and cancer of the brain |
| 07/27/2011 | EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/27/2011 | EP1419152B1 Hiv inhibiting pyrimidines derivatives |
| 07/27/2011 | EP1389616B1 3,4-Dihalobenzylpiperidine derivatives and their medical use |
| 07/27/2011 | EP1351694B2 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 07/27/2011 | EP1337240B1 Method of making particles for use in a pharmaceutical composition |
| 07/27/2011 | EP1317409B2 Method for the purification of an alpha-hydroxy acid on an industrial scale |
| 07/27/2011 | EP1312360B1 Analgesic/antiinflammatory patches for topical use |
| 07/27/2011 | EP1277466B1 Patch containing anti-inflammatory agent |
| 07/27/2011 | EP1267891B1 Antiadhesive carbohydrates |
| 07/27/2011 | EP1125585B1 Treatment of graft-versus-host disease targeting ailim |
| 07/27/2011 | EP1011743B1 Loading and release of water-insoluble drugs |
| 07/27/2011 | CN201906228U Composite structure of medicine for treating type II diabetes |
| 07/27/2011 | CN1984899B CXCR1 and CXCR2 chemokine antagonists |
| 07/27/2011 | CN1984879B Carboxamido opioid compounds |
| 07/27/2011 | CN1974558B (+)-Meptazinol diligand derivative and/or its salt and the preparation process |
| 07/27/2011 | CN1972909B Thio-substituted arylmethanesulfinyl derivatives |
| 07/27/2011 | CN1968708B Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 07/27/2011 | CN1964979B Novel water-soluble prodrug |
| 07/27/2011 | CN1933827B Use of methylene amide derivatives in preparing medicine for treating and/ or preventing heart failure |
| 07/27/2011 | CN1930139B Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 07/27/2011 | CN1919204B Method for enhancing nutrient absorption with astragalosides |
| 07/27/2011 | CN1903188B Application of teprenone for preparing medicine for treating and/or preventing glaucoma |
| 07/27/2011 | CN1823748B Medicinal preparation of coenzyme Q10 liposome and its preparation technology |
| 07/27/2011 | CN1812775B Use of pentane-1,5-diol in preparing medicine for inhibiting the growth of antibiotic-resistant of bacteria |
| 07/27/2011 | CN1756544B Use of arachidonic acid for normalization of infradian rhythm |
| 07/27/2011 | CN1747744B Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 07/27/2011 | CN1393222B Use of composition of sterol compounds dissolved in oil |